ADV36 adipogenic adenovirus in human liver disease

doi:10.3748/wjg.v20.i40.14706

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7552)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

457

WORD

282

HTML

4163

Figures (1-8)

304

Tables (1-3)

269

Sum=5475

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1083

Download

994

Sum=2077

Oct 28, 2014 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2014; 20(40): 14706-14716
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14706

Full Size Figure Download Figure

Figure 4 Odds ratio: Higher hazard of non-alcoholic fatty liver disease is associated with insulin resistance and obesity, and a lower non-alcoholic fatty liver disease risk is associated with ADV36 seropositivity. NAFLD: Nonalcoholic fatty liver disease.

Citation: Trovato FM, Catalano D, Garozzo A, Martines GF, Pirri C, Trovato GM. ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol 2014; 20(40): 14706-14716
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14706.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14706